EP2416751A1 - Use of a device for reducing adipose overloads for treating physiological disorders - Google Patents
Use of a device for reducing adipose overloads for treating physiological disordersInfo
- Publication number
- EP2416751A1 EP2416751A1 EP09784184A EP09784184A EP2416751A1 EP 2416751 A1 EP2416751 A1 EP 2416751A1 EP 09784184 A EP09784184 A EP 09784184A EP 09784184 A EP09784184 A EP 09784184A EP 2416751 A1 EP2416751 A1 EP 2416751A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- straps
- treatment
- boots
- fat
- frequency electromagnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003187 abdominal effect Effects 0.000 claims abstract description 10
- 208000001145 Metabolic Syndrome Diseases 0.000 claims abstract description 8
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims abstract description 8
- 239000004020 conductor Substances 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 5
- 230000034004 oogenesis Effects 0.000 claims description 3
- 230000021595 spermatogenesis Effects 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims description 2
- 230000016087 ovulation Effects 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 claims 1
- 230000002534 ovogenetic effect Effects 0.000 abstract 1
- 230000000624 ovulatory effect Effects 0.000 abstract 1
- 230000002199 spermatogenetic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 15
- 230000009467 reduction Effects 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- YPMOAQISONSSNL-UHFFFAOYSA-N 8-hydroxyoctyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCO YPMOAQISONSSNL-UHFFFAOYSA-N 0.000 description 3
- 208000004611 Abdominal Obesity Diseases 0.000 description 3
- 206010065941 Central obesity Diseases 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 108090000312 Calcium Channels Proteins 0.000 description 2
- 102000003922 Calcium Channels Human genes 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 102100040947 Lutropin subunit beta Human genes 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000011707 Ovulation disease Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H9/00—Pneumatic or hydraulic massage
- A61H9/005—Pneumatic massage
- A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0221—Mechanism for heating or cooling
- A61H2201/0228—Mechanism for heating or cooling heated by an electric resistance element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
Definitions
- This device is that described in WO 2008/043907, and is an apparatus for reducing fat overloads comprising a generator of low frequency electromagnetic waves, insulating straps for wrapping fat areas of the body, equipped with a conductor folded into successive strands, arranged alternately in one direction and then in the other, and a dual pressure gradient pressotherapy apparatus comprise two boots and an abdominal belt, and superimposed on said straps. It is stated in this document that this device allows a slimming process and a specific reduction of body fat.
- an apparatus for the reduction of fat overloads comprising: a generator of low frequency electromagnetic waves; o insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other; o a pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of stress.
- This fertility-positive gene induction concerns the same patients as those who showed a redistribution of cholesterol on lipid metabolism, as well as a reduction in the HOMA index, and also correspond to persons whose waist circumference has decreased significantly, there is almost perfect correlation of all these results.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a device for reducing adipose overloads, comprising: a low-frequency electromagnetic wave generator; insulating straps for surrounding the adipose areas of the body, provided with a conductor folded into consecutive strands arranged alternately in one direction and then in the other; a pressure therapy device with a double pressure gradient, comprising two boots and an abdominal belt and placed over said straps, to be used in treating metabolic syndrome, in treating ovogenetic, ovulatory and spermatogenetic disorders, and to be used in treating stress.
Description
Utilisation d'un appareil pour la réduction des surcharges adipeuses pour le traitement de troubles physiologiques. Use of a device for the reduction of fat overloads for the treatment of physiological disorders.
L'invention concerne l'utilisation d'un appareil pour la réduction des surcharges adipeuses pour le traitement de divers troubles physiologiques, en particulier l'infertilité chez l'être humain ou en cas d'obésité abdominale et de syndrome métabolique.The invention relates to the use of an apparatus for the reduction of fat overload for the treatment of various physiological disorders, in particular infertility in humans or in cases of abdominal obesity and metabolic syndrome.
On sait que l'une des causes d'une infertilité féminine peut être l'obésité abdominale et le traitement d'une telle infertilité comporte généralement un amaigrissement de la femme particulièrement au niveau de la ceinture abdominale. Cet amaigrissement peut être obtenu par un régime, une activité sportive et/ou des techniques appropriées. Le traitement est toutefois aléatoire et dans tous les cas relativement long.It is known that one of the causes of female infertility may be abdominal obesity and the treatment of such infertility usually involves a slimming of the woman particularly at the level of the abdominal belt. This weight loss can be achieved through diet, sports activity and / or appropriate techniques. The treatment is however random and in all cases relatively long.
Or, on a découvert de manière surprenante que l'utilisation d'ondes électromagnétiques basse fréquence au moyen d'un appareil d'un type particulier permet d'obtenir des résultats sur l'infertilité de manière efficace et rapide. Cet appareil est celui décrit dans WO 2008/043907, et est un appareil pour la réduction des surcharges adipeuses comprenant un générateur d'ondes électromagnétiques à basse fréquence, des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs, disposés alternativement dans un sens puis dans l'autre, et un appareil de pressothérapie à double gradient de pression comportent deux bottes et une ceinture abdominale, et superposé auxdites sangles. Il est indiqué dans ce document que cet appareil permet un processus d'amaigrissement et une réduction spécifique de la masse grasse corporelle.Surprisingly, it has been discovered that the use of low frequency electromagnetic waves by means of an apparatus of a particular type makes it possible to obtain infertility results efficiently and rapidly. This device is that described in WO 2008/043907, and is an apparatus for reducing fat overloads comprising a generator of low frequency electromagnetic waves, insulating straps for wrapping fat areas of the body, equipped with a conductor folded into successive strands, arranged alternately in one direction and then in the other, and a dual pressure gradient pressotherapy apparatus comprise two boots and an abdominal belt, and superimposed on said straps. It is stated in this document that this device allows a slimming process and a specific reduction of body fat.
Sans vouloir se lier à une quelconque théorie, il semble que l'action de cet appareil provoque une stimulation de nombreux gènes codant pour des protéines qui jouent un rôle dans le fonctionnement des canaux calciques et on a constaté à l'heure actuelle que les améliorations constatées sont de trois types : amélioration de la fertilité humaine dans certains cas d'obésité abdominale, amélioration de quatre des cinq critères du syndrome métabolique (métabolisme lipidique : cholestérol et triglycérides, résistance à l'insuline, diminution du tour de taille).Without wishing to be bound by any theory, it appears that the action of this device causes stimulation of many genes encoding proteins that play a role in the functioning of calcium channels and it has now been found that improvements There are three types of findings: improvement of human fertility in some cases of abdominal obesity, improvement of four of the five criteria of the metabolic syndrome (lipid metabolism: cholesterol and triglycerides, insulin resistance, reduced waist circumference).
Amélioration dans le traitement du stress. L'invention a donc pour objet : - un appareil pour la réduction des surcharges adipeuses, comportant : o un générateur d'ondes électromagnétiques à basse fréquence ;
o des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ; o un appareil de pressothérapie à double gradient de pression comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement du syndrome métabolique. un appareil pour la réduction des surcharges adipeuses, comportant : o un générateur d'ondes électromagnétiques à basse fréquence ; o des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ; o un appareil de pressothérapie à double gradient de pressions comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement des troubles de l'ovulation, l'ovogenèse et de la spermatogenèse. un appareil pour la réduction des surcharges adipeuses, comportant : o un générateur d'ondes électromagnétiques à basse fréquence ; o des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ; o un appareil de pressothérapie à double gradient de pressions comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement du stress.Improvement in the treatment of stress. The invention therefore relates to: an apparatus for reducing fat overloads, comprising: a generator of low frequency electromagnetic waves; o insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other; o a double pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of the metabolic syndrome. an apparatus for the reduction of fat overloads, comprising: a generator of low frequency electromagnetic waves; o insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other; o a double pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of ovulation disorders, oogenesis and spermatogenesis. an apparatus for the reduction of fat overloads, comprising: a generator of low frequency electromagnetic waves; o insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other; o a pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of stress.
Des profils d'expression pour la caractérisation des effets transcriptionnels induits dans les cellules du sang total ont été réalisés sur des patients soumis à 12 séances de l'appareil pour la réduction des surcharges adipeuses (ci-après l'appareil).Expression profiles for the characterization of induced transcriptional effects in whole blood cells were performed on patients subjected to 12 sessions of the apparatus for the reduction of fat overload (hereinafter the apparatus).
Des prélèvements sanguins ont été effectués pour chaque patient avant le début des séances, juste avant et juste après la 8eme séance et à la fin de la 12eme séance.Blood samples were taken for each patient before the start of the sessions, just before and after the 8 th meeting and at the end of the 12 th session.
Les résultats ont été obtenus à partir de l'étude du profil d'expression sur puces Agilent Whole Génome Microarray kit 4x44K comportant 43 776 séquences génétiques (hors contrôles). Ces puces ont été hybridées à des sondes correspondant aux échantillons d'ARns extraits à partir de sang total collecté dans des tubes PAXgene.The results were obtained from the study of the Agilent Whole Genome Microarray kit 4x44K expression profile comprising 43,776 genetic sequences (excluding controls). These chips were hybridized to probes corresponding to the ARns samples extracted from whole blood collected in PAXgene tubes.
La qualité et la quantité de l'ensemble des échantillons des ARNs ont été mesurées, respectivement, au moyen du Bioanalyser (Agilent) et par Nanodrop.
Un bilan biologique ainsi qu'une mesure de tour de taille ont été réalisés pour l'ensemble des patients.The quality and quantity of all samples of the RNAs were measured, respectively, using the Bioanalyser (Agilent) and Nanodrop. A biological assessment and a measurement of waist circumference were performed for all patients.
Les données ont été soumises à une normalisation intra-puces et inter-puces (méthode quantile) au moyen du logiciel R. Les rapports des intensités : après séance (b,c,d) versus avant première séance (a) ont été calculés pour chaque patient.The data were subjected to intra-chip and inter-chip normalization (quantile method) using software R. The intensity ratios: after session (b, c, d) versus before first session (a) were calculated for each patient.
Il a été effectué une sélection de gènes dont le rapport d'expression est supérieur ou égal à 2 après la 12eme séance de traitement avec l'appareil.A selection of genes whose expression ratio was greater than or equal to 2 after the 12 th treatment session with the apparatus was performed.
Cette analyse a conduit à sélectionner 112 gènes qui ont été soumis à une étude de corrélation au moyen du logiciel PredictSearch. Dans un deuxième temps, les données d'intensités obtenues après normalisation ont été filtrées sur la base : (i) intensité supérieure au bruit de fond pour l'ensemble des échantillons, (ii) rapport d'intensité supérieure à 1,5. Cette sélection a identifié 89 gènes.This analysis led to the selection of 112 genes that were subjected to a correlation study using the PredictSearch software. In a second step, the intensities data obtained after normalization were filtered on the basis of: (i) intensity greater than the background noise for all the samples, (ii) intensity ratio greater than 1.5. This selection identified 89 genes.
Au final l'action de l'appareil semble cibler les cellules musculaires et intègre des gènes associés à la contraction musculaire. Cet effet résulterait d'une modulation de l'expression de gènes codant pour des protéines qui jouent un rôle dans le fonctionnement des canaux calciques.In the end the action of the device seems to target the muscle cells and integrates genes associated with muscle contraction. This effect would result from a modulation of the expression of genes encoding proteins that play a role in the functioning of calcium channels.
Il faut distinguer le syndrome métabolique de l'obésité qui atteint l'ensemble du corps et qui ne comporte pas obligatoirement de risques cardio-vasculaires spécifiques ni de facteurs favorisant l'athérosclérose. Au niveau abdominal, la graisse se révèle bien plus dangereuse, car les adipocytes, en fort excès, libèrent de nombreuses substances toxiques qui exercent des effets néfastes sur les artères, entraînant l'apparition de maladies, telle l'athérosclérose, et des états inflammatoires. Ces adipocytes agissent aussi de façon indirecte sur la sécrétion d'insuline en induisant une insulino- résistance. Le syndrome métabolique est moins spectaculaire que l'obésité, mais son risque médical est plus élevé.The metabolic syndrome must be distinguished from obesity, which affects the whole body and does not necessarily involve specific cardiovascular risks or factors that promote atherosclerosis. In the abdomen, fat is much more dangerous because adipocytes, in large excess, release many toxic substances that have adverse effects on the arteries, leading to the development of diseases, such as atherosclerosis, and inflammatory conditions . These adipocytes also act indirectly on the secretion of insulin by inducing insulin resistance. The metabolic syndrome is less dramatic than obesity, but its medical risk is higher.
Il est déterminant de chercher à diminuer le tour de taille abdominal qui apparaît comme le point de départ du syndrome métabolique, celui-ci est particulièrement en cause dans l'insulino- résistance. Globalement, la réduction du tour de taille observée chez l'ensemble des patients (dans 90% des cas) confirme l'effet bénéfique de l'appareil.It is decisive to try to reduce the abdominal waistline, which appears to be the starting point of the metabolic syndrome, which is particularly implicated in insulin resistance. Overall, the reduction in waist circumference observed in all patients (in 90% of cases) confirms the beneficial effect of the device.
Concernant l'impact d'une redistribution du cholestérol sur le métabolisme lipidique, au regard des variations du taux de cholestérol et de triglycérides donné par les bilans biologiques, il est à
signaler que les gènes impliqués dans cette redistribution sont significativement modulés dans près de 70% des cas.Concerning the impact of a redistribution of cholesterol on the lipid metabolism, with regard to the variations of the cholesterol and triglyceride levels given by the biological balance sheets, it is report that the genes involved in this redistribution are significantly modulated in nearly 70% of cases.
Sur un autre plan, la réduction de l'indice HOMA, indice de résistance à l'insuline, chez les patients présentant une activation significative des gènes impliqués dans la restauration d'une réponse à l'insuline a été démontrée.On another level, the reduction of the HOMA index, insulin resistance index, in patients with significant activation of the genes involved in the restoration of an insulin response has been demonstrated.
On retrouve un bon parallèle entre les résultats des indices HOMA et des bilans lipidiques, avec la modulation positive des gènes, dans la mesure où il s'agit des mêmes patients concernés.A good parallel is found between the results of the HOMA indices and lipid balances, with the positive modulation of the genes, insofar as they are the same patients concerned.
Par ailleurs, il faut noter l'induction génique permettant de rendre compte des effets positifs de l'appareil sur la fertilité. En effet on a pu mettre en évidence dans cette étude l'induction de la LHB «luteinizing hormone beta polypeptide», une sous-unité de la luteinizing hormone (LH) connue pour sa capacité à stimuler l'ovulation. La LHB dont l'expression est augmentée par le calcium, active par ailleurs l'ovogenèse et la spermatogenèse.In addition, we must note the gene induction to account for the positive effects of the device on fertility. In fact, it was possible to demonstrate in this study the induction of the LHB "luteinizing hormone beta polypeptide", a subunit of the luteinizing hormone (LH) known for its ability to stimulate ovulation. LHB, whose expression is increased by calcium, also activates oogenesis and spermatogenesis.
Cette induction génique positive, au niveau de la fertilité, concerne les mêmes patients que ceux ayant montré une redistribution du cholestérol sur le métabolisme lipidique, ainsi qu'une réduction de l'indice HOMA, et correspondent également aux personnes dont le tour de taille a diminué de façon significative, il y a donc quasi parfaite corrélation de l'ensemble de ces résultats.This fertility-positive gene induction concerns the same patients as those who showed a redistribution of cholesterol on lipid metabolism, as well as a reduction in the HOMA index, and also correspond to persons whose waist circumference has decreased significantly, there is almost perfect correlation of all these results.
On note que les patients soumis à 12 séances de traitement par l'appareil présentent un stress inférieur à ce qu'il était avant. Les effets de l'appareil se font sentir d'une manière légèrement différente d'une personne à une autre selon ses particularités propres.It is noted that patients subjected to 12 treatment sessions by the device have a lower stress than it was before. The effects of the device are felt in a slightly different way from one person to another according to its own particularities.
Les effets de l'appareil persistent encore 4 à 6 semaines après l'arrêt de la dernière séance de la cure de 12 séances, ce qui semble être une relation directe avec une stimulation génique qui agirait de façon prolongée pour certains gènes.
The effects of the device still persist 4 to 6 weeks after stopping the last session of the course of 12 sessions, which seems to be a direct relationship with gene stimulation that would act for a long time for certain genes.
Claims
1. Appareil pour la réduction des surcharges adipeuses, comportant :Apparatus for reducing fat overload, comprising:
- un générateur d'ondes électromagnétiques à basse fréquence ;- a generator of low frequency electromagnetic waves;
- des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ;insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other;
- un appareil de pressothérapie à double gradient de pression comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement du syndrome métabolique. - A pressurized dual pressure gradient pressure device comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of metabolic syndrome.
2. Appareil pour la réduction des surcharges adipeuses, comportant :2. Apparatus for reducing adipose overload, comprising:
- un générateur d'ondes électromagnétiques à basse fréquence ;- a generator of low frequency electromagnetic waves;
- des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ; - un appareil de pressothérapie à double gradient de pression comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement des troubles de l'ovulation, de l'ovogenèse et de la spermatogenèse.insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other; - A double pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of disorders of ovulation, oogenesis and spermatogenesis.
3. Appareil pour la réduction des surcharges adipeuses, comportant : - un générateur d'ondes électromagnétiques à basse fréquence ;Apparatus for reducing fat overload, comprising: - a generator of low frequency electromagnetic waves;
- des sangles isolantes pour l'enveloppement des zones adipeuses du corps, équipées d'un conducteur replié en brins successifs disposés alternativement dans un sens puis dans l'autre ;insulating straps for wrapping fat areas of the body, equipped with a folded conductor in successive strands arranged alternately in one direction and then in the other;
- un appareil de pressothérapie à double gradient de pression comportant deux bottes et une ceinture abdominale, et superposé auxdites sangles, pour utilisation dans le traitement du stress. - A pressure gradient pressotherapy apparatus comprising two boots and an abdominal belt, and superimposed on said straps, for use in the treatment of stress.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/FR2009/000405 WO2010116046A1 (en) | 2009-04-06 | 2009-04-06 | Use of a device for reducing adipose overloads for treating physiological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2416751A1 true EP2416751A1 (en) | 2012-02-15 |
Family
ID=41319477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09784184A Withdrawn EP2416751A1 (en) | 2009-04-06 | 2009-04-06 | Use of a device for reducing adipose overloads for treating physiological disorders |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2416751A1 (en) |
WO (1) | WO2010116046A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3049468A1 (en) * | 2016-04-04 | 2017-10-06 | Aquamoon | MACHINE WORKSTATION FOR AESTHETIC OPERATOR FOR TISSUE FIRMING |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855415B1 (en) * | 2003-05-28 | 2006-01-06 | H C A Sa | ELECTRICAL DEVICE FOR REDUCING ADDITIONAL OVERLOADS |
FR2906727A1 (en) * | 2006-10-06 | 2008-04-11 | H C A Sa | "METHOD AND APPARATUS FOR REDUCING ADDITIONAL OVERLOADS". |
-
2009
- 2009-04-06 WO PCT/FR2009/000405 patent/WO2010116046A1/en active Application Filing
- 2009-04-06 EP EP09784184A patent/EP2416751A1/en not_active Withdrawn
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2010116046A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010116046A1 (en) | 2010-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Comparable effects of high-intensity interval training and prolonged continuous exercise training on abdominal visceral fat reduction in obese young women | |
EP2665516B1 (en) | Device for emitting a magnetic field | |
Dreibati et al. | Influence of electrical stimulation frequency on skeletal muscle force and fatigue | |
Drigny et al. | Long-term high-intensity interval training associated with lifestyle modifications improves QT dispersion parameters in metabolic syndrome patients | |
Onambélé-Pearson et al. | Influences of carbohydrate plus amino acid supplementation on differing exercise intensity adaptations in older persons: skeletal muscle and endocrine responses | |
Wozniak et al. | Laser acupuncture and low-calorie diet during visceral obesity therapy after menopause | |
Evans | Protein nutrition and resistance exercise | |
Zajac et al. | Effects of growth hormone and testosterone therapy on aerobic and anaerobic fitness, body composition and lipoprotein profile in middle-aged men | |
EP2416751A1 (en) | Use of a device for reducing adipose overloads for treating physiological disorders | |
Nakajima et al. | Effects of exercise and anti-aging | |
Ghaderi et al. | Listening to motivational music: lactate and cortisol response to a single circuit resistance exercise for young male athletes | |
Arsianti et al. | Effect of electrical stimulation in lower extremity as physical exercise in type 2 diabetes mellitus patients | |
Casillas et al. | Low-frequency electromyostimulation and chronic heart failure | |
Calyniuk et al. | The effectiveness of the low energy diet in overweight and obese adults | |
Huang et al. | Effects of neuromuscular electrical stimulation on arterial hemodynamic properties and body composition in paretic upper extremities of patients with subacute stroke | |
Eydivandi et al. | The Effect of High Intensity Interval Training (HIIT) and Crocin Consumption on Doxorubicin-Induced Apoptotic Indices in the Muscle Tissue of Rats | |
Eurcherdkul et al. | Efficacy of high intensity laser therapy in patellofemoral pain syndrome: A Double-blinded Randomized Controlled Trial | |
Son et al. | Effects of resistance circuit training on health-related physical fitness in people with paraplegia: a pilot randomized controlled trial | |
de Sire et al. | Impact of rehabilitation on volumetric muscle loss in subjects with traumatic spinal cord injury: A systematic review | |
Kim | Effects of Exercise Training with Instrument on Abdominal and Thigh Fat, Physical Fitness, and Obesity-related Cytokines in Obese Elderly Subjects. | |
Hum et al. | Lack of laterality in the effects of right and left amygdala kindling on weight gain in female rats | |
Wheeler et al. | Hormonal responses to graded-resistance, FES-assisted strength training in spinal cord-injured | |
Arranz et al. | Improvement of the interleukin 2 and tumour necrosis factor α release by blood leukocytes as well as of plasma cortisol and antioxidant levels after acupuncture treatment in women suffering anxiety | |
Zoladz | SESSION I | |
Philippou et al. | Exercise-induced Effects On Physical Performance And Growth Factors Levels In Breast Cancer Patients Undergoing Chemotherapy: 2850 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20111006 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOPASS S.A. |
|
17Q | First examination report despatched |
Effective date: 20151208 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20170221 |